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Book Reviews 91

National Research Council, Issues in Risk Assessment (National
Academy Press). Appendices, executive summary, figures, preface,
references, tables. LC 92-61838; ISBN 0-309-04786-2. [374 pp. Paper $37.50 S&H, $4 for first and $0.50 for each additional copy. 2101 Constitution Avenue,
NW, Washington DC 20418.]

Risk assessments are important to many decisions within the
Environmental Protection Agency, Occupational Safety Health
Administration, Consumer Product Safety Commission, Food and
Drug Administration and other agencies. Recent developments in risk
assessment have caused such agencies, as well as industry, to seek
1
National Research Council (NRC) guidance.
Thus, the Committee on Risk Assessment Methodology (CRAM),
consisting of experts drawn from several disciplines, was established
within the NRC Board on Environmental Studies and Toxicology of
the Commission on Life Sciences "to assess the scientific basis, inference
assumptions, and regulatory uses of and research need in risk
assessment." 2 This book contains the first three in a series of reports
addressing such issues.
Aside from a twelve page executive summary, the body of Issues in
Risk Assessment is organized into three parts that address respectively
the use of maximum tolerated dose (MTD) in animal carcinogenicity
bioassays, the two-stage model of carcinogenesis, and an ecological risk
assessment paradigm. Each part contains a report with extensive
supporting documentation. Indeed, of 344 pages containing these parts,
approximately two-thirds are given to commissioned papers in their
entirety, lists of workshop attendees and workshop agendas. Since one
of CRAM's goals is to recommend methodologies for consistent use by
scientists, this documentation should be helpful.
1 Agency liaison to CRAM were consulted regarding workshop topics and
participants. They also played a role in preparing workshop summaries but did not
participate in committee deliberations or report preparation; Issues in Risk Assessment,
at 2.
2 Id.
5 Risk: Health, Safety & Environment 75 [Wimter 1994]

In a preface, Bernard Goldstein, the CRAM chair, notes that an
important objective was "to help scientists in regulatory agencies,
academe, and industry to find common ground....,, 3 Yet, while
CRAM was able to make unanimous recommendations in the second
and third parts of the book, ironically, it could not itself achieve
consensus on MTD use. Thus, that report contains both "majority" and
"minority" opinions and "reflects differing judgments on which
approach to carcinogenicity testing would be most effective in
4
providing information to assist risk managers."
One has the impression that some of the detail in appendice , most
notably in the first part, could easily have been omitted. Perhaps it was
included because the committee could not find "common ground." If
so, CRAM is to be commended for fully setting forth support for
recommendations in areas of potential disagreement.
CRAM expects next to examine exposure assessment and
developmental toxicity. If reports on those topics follow the same
format as ones addressed in Issues in Risk Assessment, scientists will
have as much guidance as possible in making consistent risk
assessments. Where uncontroverted guidance is impossible, this will
frustrate scientists seeking bright line rules, but others involved in risk
assessment and management will want to pay close attention. Such
circumstances highlight issues that cannot, at least for the moment, be
5
characterized as primarily "technical."
Diane M. Albert t

3

Id atxi.

4 Id. at 8; see also 19 and 64.
5 See, e.g., Academy Splits on Risk, 259 Science 759 (1993) - quoting CRAM
staff project director, Gail Charnley: "It's an ideological argument. But we just don't
know which [MTD group] is right."
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